Related Experiment Video
Updated: Dec 22, 2025
08:30
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
3.0K
Update and breakthrough in cardiac xenotransplantation
1Department of Cardiac Surgery, LMU Munich University Hospital, Klinikum Grosshadern, Ludwig-Maximillians-University Munich, Munich, Germany.
Current Opinion in Organ Transplantation
|May 7, 2020
Summary
Cardiac xenotransplantation shows promise for prolonged survival, nearing clinical application. Further research into genetic modifications and immunological safety is crucial for human use in selected patients.
Area of Science:
- Cardiovascular Surgery
- Transplantation Immunology
- Xenotransplantation
Background:
- Cardiac xenotransplantation has advanced significantly, with recent developments enabling prolonged survival of cardiac xenografts.
- These advancements are bringing clinical applications closer to reality.
Purpose of the Study:
- To review recent findings and summarize the current state of cardiac xenotransplantation.
- To discuss the potential for clinical implications and future research directions.
Main Methods:
- Combination of genetic modifications in porcine xenografts.
- Novel immunosuppression strategies including costimulation blockade.
- Supporting therapies: anti-inflammatory treatment, growth prevention, and optimized organ procurement to minimize ischemia-reperfusion injury.
Main Results:
- Improved cardiac xenograft function and survival in nonhuman primate models.
- Identification of novel xenoantigens and advancements in gene-editing techniques.
- Enhanced understanding of strategies to reduce myocardial ischemia and reperfusion injury.
Conclusions:
- Cardiac xenotransplantation is approaching clinical feasibility.
- Further investigation into infectious and immunological implications for human recipients is essential.
- Initial clinical use will be restricted to highly selected patient populations.
